154 related articles for article (PubMed ID: 26276769)
21. World Health Organization-defined eosinophilic disorders: 2014 update on diagnosis, risk stratification, and management.
Gotlib J
Am J Hematol; 2014 Mar; 89(3):325-37. PubMed ID: 24577808
[TBL] [Abstract][Full Text] [Related]
22. A novel acquired cryptic three-way translocation t(2;11;5)(p21.3;q13.5;q23.2) with a submicroscopic deletion at 11p14.3 in an adult with hypereosinophilic syndrome.
Kjeldsen E
Exp Mol Pathol; 2015 Aug; 99(1):50-5. PubMed ID: 25962659
[TBL] [Abstract][Full Text] [Related]
23. Myeloid and lymphoid neoplasms with eosinophilia and abnormalities of PDGFRA, PDGFRB or FGFR1.
Bain BJ
Haematologica; 2010 May; 95(5):696-8. PubMed ID: 20442440
[No Abstract] [Full Text] [Related]
24. Clinical Response to Upfront Targeted Tyrosine Kinase Inhibitors among Patients with Myeloid/Lymphoid Neoplasms with Eosinophilia and Tyrosine Kinase Gene Fusion.
Zhang Y; Nguyen L; Lu CM; Wang E; Lauw MIS; Ball S; Dong N; Moscinski L; Chan O; Yun S; Sallman D; Sokol L; Shah B; Knepper T; Lancet J; Komrokji R; Padron E; Kuykendall A; Zhang L
Clin Lymphoma Myeloma Leuk; 2023 Mar; 23(3):e150-e163. PubMed ID: 36624015
[TBL] [Abstract][Full Text] [Related]
25. Molecular genetic characterization of myeloid/lymphoid neoplasms associated with eosinophilia and rearrangement of
Baer C; Muehlbacher V; Kern W; Haferlach C; Haferlach T
Haematologica; 2018 Aug; 103(8):e348-e350. PubMed ID: 29567772
[No Abstract] [Full Text] [Related]
26. Eosinophilic myeloid disorders: new classification and novel therapeutic strategies.
Gotlib J
Curr Opin Hematol; 2010 Mar; 17(2):117-24. PubMed ID: 20071982
[TBL] [Abstract][Full Text] [Related]
27. Rare and potentially fatal - Cytogenetically cryptic TNIP1::PDGFRB and PCM1::FGFR1 fusion leading to myeloid/lymphoid neoplasms with eosinophilia in children.
Berking AC; Flaadt T; Behrens YL; Yoshimi A; Leipold A; Holzer U; Lang P; Quintanilla-Martinez L; Schlegelberger B; Reiter A; Niemeyer C; Strahm B; Göhring G
Cancer Genet; 2023 Apr; 272-273():29-34. PubMed ID: 36657267
[TBL] [Abstract][Full Text] [Related]
28. [Heterogenous abnormality polymorphism of gene PDGFRB in myeloid neoplasms and its clinical characteristics].
Wang QS; Gao L; Jing Y; Zhu HY; Yang H; Yu L
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Apr; 20(2):291-5. PubMed ID: 22541084
[TBL] [Abstract][Full Text] [Related]
29. Novel t(5;11)(q32;q13.4) with NUMA1-PDGFRB fusion in a myeloid neoplasm with eosinophilia with response to imatinib mesylate.
Zou YS; Hoppman NL; Singh ZN; Sawhney S; Kotiah SD; Baer MR
Cancer Genet; 2017 Apr; 212-213():38-44. PubMed ID: 28449810
[TBL] [Abstract][Full Text] [Related]
30. A novel TRIP11-FLT3 fusion in a patient with a myeloid/lymphoid neoplasm with eosinophilia.
Chung A; Hou Y; Ohgami RS; Von Gehr A; Fisk DG; Roskin KM; Li X; Gojenola L; Bangs CD; Arber DA; Fire AZ; Cherry AM; Zehnder JL; Gotlib J; Merker JD
Cancer Genet; 2017 Oct; 216-217():10-15. PubMed ID: 29025582
[TBL] [Abstract][Full Text] [Related]
31. Myeloid/Lymphoid Neoplasms with Eosinophilia and TK Fusion Genes, Version 3.2021, NCCN Clinical Practice Guidelines in Oncology.
Gerds AT; Gotlib J; Bose P; Deininger MW; Dunbar A; Elshoury A; George TI; Gojo I; Gundabolu K; Hexner E; Hobbs G; Jain T; Jamieson C; Kuykendall AT; McMahon B; Mohan SR; Oehler V; Oh S; Pardanani A; Podoltsev N; Ranheim E; Rein L; Salit R; Snyder DS; Stein BL; Talpaz M; Thota S; Vachhani P; Wadleigh M; Walsh K; Ward DC; Bergman MA; Sundar H
J Natl Compr Canc Netw; 2020 Sep; 18(9):1248-1269. PubMed ID: 32886902
[TBL] [Abstract][Full Text] [Related]
32. Review of current classification, molecular alterations, and tyrosine kinase inhibitor therapies in myeloproliferative disorders with hypereosinophilia.
Havelange V; Demoulin JB
J Blood Med; 2013; 4():111-21. PubMed ID: 23976869
[TBL] [Abstract][Full Text] [Related]
33. Identification of a Novel CSNK2A1-PDGFRB Fusion Gene in a Patient with Myeloid Neoplasm with Eosinophilia.
Xu X; Lu Q; Wang Z; Cai P; Zeng Z; Zhang L; Wang M; Ma L; Ruan C; Chen S
Cancer Res Treat; 2021 Jul; 53(3):889-892. PubMed ID: 33421986
[TBL] [Abstract][Full Text] [Related]
34. ALK gene aberrations and the JUN/JUNB/PDGFR axis in metastatic NSCLC.
Berghoff AS; Birner P; Streubel B; Kenner L; Preusser M
APMIS; 2014 Sep; 122(9):867-72. PubMed ID: 24750504
[TBL] [Abstract][Full Text] [Related]
35. A Case of a Very Young Child With T Lymphoblastic Lymphoma With Eosinophilia and PDGFRB Translocation: A Rare Form of Myeloid/Lymphoid Neoplasm Associated With Eosinophilia and Rearrangements of PDGFRA, PDGFRB or FGFR1.
Grimes AB; Miller MB; Elghetany MT; Marcogliese AN; Schafer ES
Clin Lymphoma Myeloma Leuk; 2020 Dec; 20(12):e990-e993. PubMed ID: 32921591
[No Abstract] [Full Text] [Related]
36. Molecular and cytogenetic characterization of a novel translocation t(4;22) involving the breakpoint cluster region and platelet-derived growth factor receptor-alpha genes in a patient with atypical chronic myeloid leukemia.
Safley AM; Sebastian S; Collins TS; Tirado CA; Stenzel TT; Gong JZ; Goodman BK
Genes Chromosomes Cancer; 2004 May; 40(1):44-50. PubMed ID: 15034867
[TBL] [Abstract][Full Text] [Related]
37. Identification of a MYO18A-PDGFRB fusion gene in an eosinophilia-associated atypical myeloproliferative neoplasm with a t(5;17)(q33-34;q11.2).
Walz C; Haferlach C; Hänel A; Metzgeroth G; Erben P; Gosenca D; Hochhaus A; Cross NC; Reiter A
Genes Chromosomes Cancer; 2009 Feb; 48(2):179-83. PubMed ID: 19006078
[TBL] [Abstract][Full Text] [Related]
38. Systematic use of fluorescence in-situ hybridisation and clinicopathological features in the screening of PDGFRB rearrangements of patients with myeloid/lymphoid neoplasms.
Fang H; Tang G; Loghavi S; Greipp P; Wang W; Verstovsek S; Medeiros LJ; Reichard KK; Miranda RN; Wang SA
Histopathology; 2020 Jun; 76(7):1042-1054. PubMed ID: 32083752
[TBL] [Abstract][Full Text] [Related]
39. The myeloproliferative neoplasms including the eosinophilia-related myeloproliferations associated with tyrosine kinase mutations: changes and issues in classification and diagnosis criteria.
Anastasi J
Semin Diagn Pathol; 2011 Nov; 28(4):304-13. PubMed ID: 22195408
[TBL] [Abstract][Full Text] [Related]
40. The World Health Organization (WHO) classification of tumors of the hematopoietic and lymphoid tissues: an overview with emphasis on the myeloid neoplasms.
Vardiman JW
Chem Biol Interact; 2010 Mar; 184(1-2):16-20. PubMed ID: 19857474
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]